DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,871 filers reported holding DANAHER CORPORATION in Q3 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,208,586 | -2.7% | 8,902 | 0.0% | 0.75% | +7.0% |
| Q2 2023 | $2,270,544 | +7.7% | 8,902 | 0.0% | 0.70% | +1.9% |
| Q1 2023 | $2,108,973 | -9.7% | 8,902 | +1.1% | 0.69% | -13.4% |
| Q4 2022 | $2,336,227 | +2.8% | 8,802 | 0.0% | 0.80% | -8.7% |
| Q3 2022 | $2,273,000 | +1.9% | 8,802 | 0.0% | 0.87% | -0.8% |
| Q2 2022 | $2,231,000 | -13.6% | 8,802 | 0.0% | 0.88% | -7.7% |
| Q1 2022 | $2,582,000 | -10.8% | 8,802 | 0.0% | 0.95% | -9.6% |
| Q4 2021 | $2,896,000 | +8.1% | 8,802 | 0.0% | 1.05% | -4.0% |
| Q3 2021 | $2,680,000 | +14.8% | 8,802 | +1.1% | 1.10% | +15.0% |
| Q2 2021 | $2,335,000 | +19.2% | 8,702 | 0.0% | 0.96% | +9.3% |
| Q1 2021 | $1,959,000 | +1.3% | 8,702 | 0.0% | 0.87% | -5.9% |
| Q4 2020 | $1,933,000 | +8.4% | 8,702 | +5.0% | 0.93% | -4.4% |
| Q3 2020 | $1,784,000 | +21.8% | 8,286 | 0.0% | 0.97% | +14.4% |
| Q2 2020 | $1,465,000 | +27.7% | 8,286 | 0.0% | 0.85% | +4.4% |
| Q1 2020 | $1,147,000 | -9.8% | 8,286 | 0.0% | 0.81% | +16.3% |
| Q4 2019 | $1,272,000 | +6.3% | 8,286 | 0.0% | 0.70% | -0.8% |
| Q3 2019 | $1,197,000 | +1.1% | 8,286 | 0.0% | 0.71% | -1.9% |
| Q2 2019 | $1,184,000 | +8.2% | 8,286 | 0.0% | 0.72% | +5.6% |
| Q1 2019 | $1,094,000 | +29.2% | 8,286 | +0.9% | 0.68% | +14.4% |
| Q4 2018 | $847,000 | -5.2% | 8,216 | 0.0% | 0.60% | +13.7% |
| Q3 2018 | $893,000 | +10.1% | 8,216 | 0.0% | 0.52% | +1.9% |
| Q2 2018 | $811,000 | +0.9% | 8,216 | 0.0% | 0.51% | -1.7% |
| Q1 2018 | $804,000 | +5.4% | 8,216 | 0.0% | 0.52% | +9.2% |
| Q4 2017 | $763,000 | +8.2% | 8,216 | 0.0% | 0.48% | +2.8% |
| Q3 2017 | $705,000 | +1.7% | 8,216 | 0.0% | 0.47% | -2.1% |
| Q2 2017 | $693,000 | -0.4% | 8,216 | +0.9% | 0.48% | -2.5% |
| Q1 2017 | $696,000 | +219.3% | 8,143 | +256.5% | 0.49% | +142.8% |
| Q1 2016 | $218,000 | +4.3% | 2,284 | 0.0% | 0.20% | +0.5% |
| Q4 2015 | $209,000 | -82.1% | 2,284 | -83.3% | 0.20% | -79.5% |
| Q2 2015 | $1,168,000 | +4.3% | 13,650 | +3.4% | 0.97% | +1.0% |
| Q1 2015 | $1,120,000 | -1.0% | 13,200 | 0.0% | 0.96% | +0.7% |
| Q4 2014 | $1,131,000 | – | 13,200 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |